TOP1 and cancer: Out of all the lesions that TDP1 repairs, TOP1-CCs are the preferred substrates and have received the most interest because of their antireplicative properties, which can be used in cancer therapy by employing agents that stabilize TOP1-CCs, such as camptothecin (CPT) and its water-soluble analog topotecan (TPT) (16).